We are focused on driving groundbreaking #CGT medicines from clinical development to commercial success. Watch Joe DePinto’s presentation at last month’s Alliance for Regenerative Medicine conference where he spoke to how we are working to get these treatments to the patients who need them. https://lnkd.in/gpt-PNAB #CGMesa24 #CellandGeneTherapy #GeneTherapy #CellTherapy
InspiroGene by McKesson
医院和医疗保健
Irving，Texas 288 位关注者
Bridging the gap between cell and gene therapy innovation and reality.
关于我们
Backed by the extensive supply chain expertise of McKesson, InspiroGene is focused on enabling manufacturers, payers, and providers to navigate the complex cell and gene therapy (CGT) commercialization landscape to ensure patients can access the life-changing treatments they need. With unparalleled experience in every stage of the CGT life cycle, InspiroGene offers a premier suite of services that are flexible and scalable.
- 网站
-
https://inspirogene.com/
InspiroGene by McKesson的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 超过 10,001 人
- 总部
- Irving，Texas
- 类型
- 上市公司
- 创立
- 2022
地点
-
主要
获取路线
US，Texas，Irving，75039
动态
-
We are working to address some of the #CGT industry's toughest challenges, from managing complex supply chains to improving patient access. Read more about the state of CGT, the launch of the InspiroGene brand, and how we’re meeting the needs of today’s patients and tomorrow’s therapies in Precision Medicine Online: https://lnkd.in/gz2JJnRT Thank you Jessica Kim Cohen?for the thoughtful feature. #CellAndGeneTherapy #HealthcareInnovation
-
-
Save the Date: Fierce Life Sciences Events’ Fierce Cell and Gene Virtual Event is November 20, 2024. Joe DePinto, the Head of Cell, Gene and Advanced Therapies at McKesson, will speak on Transforming Patient Care by Meeting the Challenges of CGT. Register here: https://lnkd.in/gisDZK6T #FierceBiotech #CellAndGene #Biotech #GeneTherapy #CellTherapy #AdvancedTherapies
-
-
We are proud to support Vertex Pharmaceuticals?to expand distribution options for CASGEVY, the first CRISPR-based gene-editing therapy for the treatment of sickle cell disease (SCD) and transfusion-dependent β-thalassemia (TDT). This partnership marks a significant step forward in bringing innovative therapies to patients in need. Learn more: https://lnkd.in/g2p7bfCt #CGT #CellandGeneTherapy #SickleCellDisease
-
-
Innovation in cell and gene therapy (CGT) is happening at a rapid pace, with thousands of drugs in the development pipeline across a broad range of therapeutic categories. The 2024 Cell and Gene Therapy Report offers a comprehensive snapshot of the field's current state, ensuring leaders have the most up-to-date information to drive impactful results. Download the report today and stay informed on the trends shaping the future of CGT, including more insights from Ellen Keeler Moore: https://lnkd.in/gRR6hv68 #StateofCGT #CGTLeader #CellandGeneTherapy #GeneTherapy #CellTherapy
-
-
The need for standards and common processes in cell and gene therapy (#CGT) is more urgent than ever. These shared standards will help drive efficiency and improve patient safety across the board. AABB has taken the lead in developing CGT Standards for Pharmacy. We encourage all industry experts and leaders to review the draft standards and provide feedback by December 16. Your input will help to ensure the delivery of consistent, high-quality CGT care. #CellAndGeneTherapy #IndustryStandards #HealthcareInnovation
AABB is pleased to introduce the proposed first edition of Cell and Gene Therapy Standards for Pharmacy, open for public comment until Dec. 16. This initiative represents a significant advancement in ensuring quality and safety for cell and gene therapy (CGT) products in pharmacy settings. As the approval of CGTs increases, pharmacies are becoming essential in managing these complex therapies. AABB’s proposed standards will address the existing gaps in pharmacy quality programs and certifications, providing guidance on the receipt, storage, handling and dispensing of CGTs. We invite all stakeholders to review the draft standards and share their comments over the next 60 days. Your insights will help finalize this critical initiative to enhance patient safety and product integrity. Learn more and submit your feedback: https://bit.ly/3NpOwEh #Biotherapies #CellTherapy #GeneTherapy #CGT #Quality
-
-
Listen to this week’s Oncology Data Advisor podcast with Joe DePinto, Head of Cell, Gene and Advanced Therapies at McKesson, to learn about our approach to navigating the complex #CGT landscape, as well as key insights from our recently published 2024 Cell and Gene Therapy report. https://lnkd.in/grvvkWHx #CellandGeneTherapy #GeneTherapy #CellTherapy #Oncology
-
-
Check out this inspiring podcast from Joe DePinto, ZS Associates and Maria Whitman
The #CGT ecosystem is full of innovation, not only in the science, but how we commercialize, distribute and finance these revolutionary treatments. I recently shared my perspective on the evolution of the CGT landscape and how new approaches like AI and data-sharing can play a role in the value chain to ultimately bring new treatments to patients. Thank you ZS Associates and Maria Whitman for hosting me. Listen here: https://lnkd.in/dPj82WNV
-
-
We are proud to sponsor Fierce Life Sciences Events’ Fierce Cell and Gene Virtual Event on November 20. Learn more about the event and register below:
We are thrilled to announce InspiroGene by McKesson as a proud partner for the Fierce Cell and Gene Virtual Event! Join us November 20 to explore the latest insights and challenges in cell and gene therapies, as industry leaders tackle key issues like safety, manufacturing, infrastructure, and cost-effectiveness in advanced treatments: https://ow.ly/PBjo50TNI0K ?Interested in becoming a #FierceCellandGene partner? Learn more about partnership opportunities: https://ow.ly/rQhw50TNI2y Stay updated on our events by following Fierce Life Sciences Events #FierceBiotech #CellAndGene #Biotech #GeneTherapy #CellTherapy #AdvancedTherapies
-
-
A massive wave of new cell and gene therapies is approaching, and Robert Richards, the Corporate Director of Cell Therapy and Transplant at the Penn Medicine, University of Pennsylvania Health System, is trying to prepare the healthcare industry for the swell as best as possible. Read more: https://lnkd.in/gn9d2gGK #StateofCGT #CellandGeneTherapy #GeneTherapy #CellTherapy
-